Tomohisa Baba Selected Research

Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

4/2021	Radiographic features and poor prognostic factors of interstitial lung disease with nivolumab for non-small cell lung cancer.
4/2021	Treatment and relapse of interstitial lung disease in nivolumab-treated patients with non-small cell lung cancer.
8/2020	Real-world use of osimertinib for epidermal growth factor receptor T790M-positive non-small cell lung cancer in Japan.
8/2020	Small-cell lung carcinoma transformation of lung adenocarcinoma diagnosed by pericardial effusion: A case report.
12/2019	Phase I study of TAS-121, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, in patients with non-small-cell lung cancer harboring EGFR mutations.
12/2019	Phase II study of nab-paclitaxel + carboplatin for patients with non-small-cell lung cancer and interstitial lung disease.
6/2019	Radiologic features of pneumonitis associated with nivolumab in non-small-cell lung cancer and malignant melanoma.
1/2018	Isolated Brain Metastases as the First Relapse After the Curative Surgical Resection in Non-Small-Cell Lung Cancer Patients With an EGFR Mutation.
6/2016	Safety and efficacy of S-1 in combination with carboplatin in non-small cell lung cancer patients with interstitial lung disease: a pilot study.
1/2016	Promising Effect of Crizotinib on Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small Cell Lung Cancer in an Elderly Patient with a Poor Performance Status: A Case Report and Literature Review.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tomohisa Baba Research Topics

Disease

32	Interstitial Lung Diseases (Interstitial Lung Disease) 10/2022 - 05/2014
25	Neoplasms (Cancer) 01/2022 - 07/2005
11	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2021 - 07/2015
10	Idiopathic Pulmonary Fibrosis 06/2022 - 09/2013
8	Bronchiectasis 12/2020 - 01/2016
7	Lung Neoplasms (Lung Cancer) 07/2022 - 08/2010
6	Adenocarcinoma of Lung 07/2022 - 01/2016
6	Disease Progression 06/2022 - 09/2013
6	Neoplasm Metastasis (Metastasis) 12/2021 - 01/2016
5	Fibrosis (Cirrhosis) 07/2022 - 05/2017
5	Leukemia 03/2021 - 11/2013
5	Pneumonia (Pneumonitis) 12/2020 - 01/2019
4	Breast Neoplasms (Breast Cancer) 12/2021 - 01/2016
4	Dyspnea (Shortness of Breath) 11/2021 - 01/2016
4	Pulmonary Fibrosis (Fibrosing Alveolitis) 11/2021 - 01/2014
4	Infections 01/2020 - 07/2006
4	Body Weight (Weight, Body) 12/2019 - 01/2014
4	Pulmonary Tuberculosis 12/2019 - 11/2008
4	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 10/2008
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2016 - 03/2009
4	Adenocarcinoma 01/2016 - 05/2014
4	Inflammation (Inflammations) 01/2012 - 03/2006
3	Pulmonary Alveolar Proteinosis 10/2022 - 05/2018
3	COVID-19 07/2022 - 11/2020
3	Systemic Scleroderma (Systemic Sclerosis) 01/2022 - 01/2016
3	Anorexia 01/2021 - 09/2013
3	Hypoxia (Hypoxemia) 12/2020 - 10/2009
3	Pneumothorax 11/2020 - 07/2008
3	Asthma (Bronchial Asthma) 05/2020 - 01/2020
3	Tuberculosis (Tuberculoses) 12/2019 - 03/2008
3	Idiopathic Interstitial Pneumonias 11/2019 - 01/2016
3	Lung Diseases (Lung Disease) 10/2018 - 01/2017
3	Colitis 01/2016 - 07/2010
3	Carcinogenesis 01/2016 - 01/2012
2	Pericardial Effusion 07/2022 - 08/2020
2	Hemorrhage 07/2022 - 05/2014
2	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 01/2022 - 04/2021
2	Esophageal Neoplasms (Esophageal Cancer) 11/2020 - 01/2017
2	Drug-Related Side Effects and Adverse Reactions 08/2020 - 05/2016
2	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 05/2020 - 03/2020
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2020 - 07/2009
2	Bacterial Infections (Bacterial Infection) 01/2020 - 03/2016
2	Liver Diseases (Liver Disease) 12/2019 - 02/2009
2	Hypersensitivity (Allergy) 09/2019 - 04/2014
2	Brain Neoplasms (Brain Tumor) 01/2018 - 11/2017
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 08/2017 - 02/2016
2	Cysts 01/2016 - 01/2016

Drug/Important Bio-Agent (IBA)

13	ChemokinesIBA 01/2018 - 03/2006
7	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2022 - 01/2017
7	Pharmaceutical PreparationsIBA 01/2022 - 11/2008
7	ErbB Receptors (EGF Receptor)IBA 01/2021 - 01/2016
6	nintedanibIBA 06/2022 - 03/2016
6	Proteins (Proteins, Gene)FDA Link 12/2021 - 03/2009
5	pirfenidoneIBA 06/2022 - 09/2013
5	LigandsIBA 12/2021 - 03/2008
5	CytokinesIBA 03/2015 - 01/2005
4	Immunoglobulins (Immunoglobulin)IBA 07/2021 - 01/2017
4	osimertinibIBA 01/2021 - 08/2020
3	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 07/2022 - 01/2016
3	Peroxidase (Myeloperoxidase)IBA 07/2022 - 01/2016
3	AntigensIBA 01/2022 - 01/2012
3	Immunoglobulin G (IgG)IBA 01/2022 - 01/2017
3	AntibodiesIBA 04/2021 - 01/2018
3	Monoclonal AntibodiesIBA 04/2021 - 01/2020
3	NivolumabIBA 04/2021 - 06/2019
3	AfatinibIBA 01/2021 - 01/2016
3	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 09/2019 - 07/2014
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 08/2017 - 02/2004
3	Chemokine CCL3IBA 01/2016 - 11/2008
3	Bevacizumab (Avastin)FDA Link 11/2015 - 05/2014
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2015 - 03/2008
3	Dextran SulfateIBA 09/2014 - 07/2010
2	Acetaminophen (Paracetamol)FDA LinkGeneric 10/2022 - 10/2020
2	Glycine-tRNA LigaseIBA 10/2022 - 12/2016
2	Midazolam (Versed)FDA LinkGeneric 11/2021 - 01/2021
2	C-Reactive ProteinIBA 04/2021 - 07/2014
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 03/2015
2	Methylprednisolone FDA LinkGeneric 12/2020 - 11/2020
2	SteroidsIBA 11/2020 - 03/2020
2	Surface-Active Agents (Surfactants)IBA 10/2020 - 07/2014
2	Small Interfering RNA (siRNA)IBA 10/2020 - 03/2009
2	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 05/2020 - 01/2018
2	Ethambutol (Myambutol)FDA LinkGeneric 12/2019 - 05/2016
2	Tyrosine Kinase InhibitorsIBA 12/2019 - 02/2016
2	Serum AlbuminIBA 12/2019 - 01/2014
2	IFIH1 Interferon-Induced HelicaseIBA 09/2019 - 01/2016
2	Biomarkers (Surrogate Marker)IBA 09/2019 - 07/2014
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2018 - 09/2015
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 11/2017 - 01/2016
2	Carboplatin (JM8)FDA LinkGeneric 06/2016 - 07/2015
2	Chemokine ReceptorsIBA 01/2016 - 10/2008

Therapy/Procedure

13	Therapeutics 06/2022 - 09/2013
11	Drug Therapy (Chemotherapy) 07/2022 - 10/2009
8	Traction 12/2020 - 01/2016
4	Transplantation 03/2021 - 02/2004
3	Immunotherapy 01/2022 - 08/2010
2	Radiotherapy 07/2022 - 01/2021
2	Thoracotomy 11/2020 - 01/2017
2	Bronchial Thermoplasty 03/2020 - 01/2020